Martinus Rabelink
- Naam
- Ing. M.J.W.E. Rabelink
- Telefoon
- +31 71 526 9111
- m.j.w.e.rabelink@lumc.nl
- Faculteit Geneeskunde
- Divisie 4
- Cel en Chemische biologie
- Spijker, H.S.; Song, H.; Ellenbroek, J.H.; Roefs, M.M.; Engelse, M.A.; Bos, E.; Koster, A.J.; Rabelink, T.J.; Hansen, B.C.; Clark, A.; Carlotti, F. & Koning, E.J.P. de (2015), Loss of beta-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits, Diabetes 64(8): 2928-2938.
- Uil, T.G.; Vellinga, J.; Vrij, J. de; Hengel, S.K. van den; Rabelink, M.J.W.E.; Cramer, S.J.; Eekels, J.J.M.; Ariyurek, Y.; Galen, M. van & Hoeben, R.C. (2011), Directed adenovirus evolution using engineered mutator viral polymerases, Nucleic Acids Research 39(5).
- Zaldumbide, A.; Weening, S.; Cramer, S.J.; Rabelink, M.J.W.E.; Verhaagen, J. & Hoeben, R.C. (2010), A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator, Biotechnology Letters 32(6): 749-754.
- Lam, S.; Lodder, K.; Teunisse, A.F.A.S.; Rabelink, M.J.W.E.; Schutte, M. & Jochemsen, A.G. (2010), Role of Mdm4 in drug sensitivity of breast cancer cells, Oncogene 29(16): 2415-2426.
- Uil TG, de Vrij J, Vellinga J, Rabelink MJWE, Cramer SJ, Chan OYA, Pugnali M, Magnusson M, Lindholm L & Boulanger P (2009), A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers, Journal of Gene Medicine 11(11): 990-1004.
- Vellinga J, Uil TG, de Vrij J, Rabelink MJWE, Lindholm L & Hoeben RC (2006), A system for efficient generation of adenovirus protein IX-producing helper cell lines.
- de Poorter JJ, Toboom TCA, Rabelink MJWE, Pieterman E, Hoeben RC, Nelissen RGHH & Huizinga TWJ (2005), Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954, Journal of Gene Medicine 7(11).
- Bazuine M, Carlotti F, Rabelink MJWE, Vellinga J, Hoeben RC & Maassen JA (2005), The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state, Endocrinology 146(4).
- Vellinga J, van den Wollenberg DJM, van der Heijdt S, Rabelink MJWE & Hoeben RC (2005), The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability, Journal of Virology 79(5).
- Vellinga J, Rabelink MJWE, Cramer SJ, van den Wollenberg DJM, Van der Meulen H, Leppard KN, Fallaux FJ & Hoeben RC (2004), Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX, Journal of Virology 78(7).
- Verwijnen SM, Smith PAES, Hoeben RC, Rabelink MJWE, Wiebe L, Curiel DT, Hemminki A, Krenning EP & de Jong M (2004), Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene, Cancer Biotherapy and Radiopharmaceuticals 19(1).
- Abou El Hassan MAI, Rabelink MJWE, van der Vijgh WJF, Bast A & Hoeben RC (2003), A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro, British Journal of Cancer 89(11).
- El Hassan MAIA, Heijn M, Rabelink MJWE, van der Vijgh WJF, Bast A & Hoeben RC (2003), The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells, Cancer Gene Therapy 10(4).
- Rademaker HJ, Abou El Hassan MA, Versteeg GA, Rabelink MJWE & Hoeben RC (2002), Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes, Journal of General Virology 83.